JP2023521163A5 - - Google Patents
Info
- Publication number
- JP2023521163A5 JP2023521163A5 JP2022561997A JP2022561997A JP2023521163A5 JP 2023521163 A5 JP2023521163 A5 JP 2023521163A5 JP 2022561997 A JP2022561997 A JP 2022561997A JP 2022561997 A JP2022561997 A JP 2022561997A JP 2023521163 A5 JP2023521163 A5 JP 2023521163A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- respiratory syndrome
- international
- syndrome coronavirus
- coronavirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063008486P | 2020-04-10 | 2020-04-10 | |
| US63/008,486 | 2020-04-10 | ||
| US202063062599P | 2020-08-07 | 2020-08-07 | |
| US63/062,599 | 2020-08-07 | ||
| PCT/US2021/026302 WO2021207443A1 (en) | 2020-04-10 | 2021-04-08 | Methods of treating sars-cov-2 infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521163A JP2023521163A (ja) | 2023-05-23 |
| JP2023521163A5 true JP2023521163A5 (https=) | 2024-04-11 |
Family
ID=75787221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561997A Pending JP2023521163A (ja) | 2020-04-10 | 2021-04-08 | Ｓａｒｓ－ｃｏｖ－２感染症を治療する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12605364B2 (https=) |
| EP (1) | EP4132518B1 (https=) |
| JP (1) | JP2023521163A (https=) |
| KR (1) | KR20230002371A (https=) |
| CN (1) | CN115361947A (https=) |
| AU (1) | AU2021253866A1 (https=) |
| BR (1) | BR112022020193A2 (https=) |
| CA (1) | CA3174710A1 (https=) |
| IL (1) | IL296517A (https=) |
| MX (1) | MX2022012705A (https=) |
| WO (1) | WO2021207443A1 (https=) |
| ZA (1) | ZA202210474B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021254415A1 (en) * | 2020-04-10 | 2022-10-20 | Eagle Pharmaceuticals, Inc. | Methods of treating Severe Acute Respiratory Syndrome |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY201417A (en) * | 2017-10-20 | 2024-02-21 | Eagle Res Labs Limited | Dantrolene prodrugs and methods of their use |
| US11123328B2 (en) | 2017-11-14 | 2021-09-21 | University Health Network | Dantrolene and analogs thereof for the chronic treatment and prevention of dyssynchronous cardiac dysfunction |
| WO2019175761A1 (en) | 2018-03-12 | 2019-09-19 | Orbicular Pharmaceutical Technologies Private Limited | Ready to use dantrolene compositions |
| US12246028B2 (en) * | 2018-11-27 | 2025-03-11 | Eagle Research Labs Limited | Use of dantrolene and dantrolene prodrugs to treat radiation exposure |
| AU2021254415A1 (en) * | 2020-04-10 | 2022-10-20 | Eagle Pharmaceuticals, Inc. | Methods of treating Severe Acute Respiratory Syndrome |
-
2021
- 2021-04-08 US US17/995,602 patent/US12605364B2/en active Active
- 2021-04-08 BR BR112022020193A patent/BR112022020193A2/pt unknown
- 2021-04-08 EP EP21723473.1A patent/EP4132518B1/en active Active
- 2021-04-08 AU AU2021253866A patent/AU2021253866A1/en active Pending
- 2021-04-08 CN CN202180027309.8A patent/CN115361947A/zh active Pending
- 2021-04-08 CA CA3174710A patent/CA3174710A1/en active Pending
- 2021-04-08 KR KR1020227034976A patent/KR20230002371A/ko active Pending
- 2021-04-08 WO PCT/US2021/026302 patent/WO2021207443A1/en not_active Ceased
- 2021-04-08 MX MX2022012705A patent/MX2022012705A/es unknown
- 2021-04-08 IL IL296517A patent/IL296517A/en unknown
- 2021-04-08 JP JP2022561997A patent/JP2023521163A/ja active Pending
-
2022
- 2022-09-21 ZA ZA2022/10474A patent/ZA202210474B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Balmeh et al. | Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors | |
| Elebeedy et al. | In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus | |
| Chen et al. | Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro | |
| JP2013537891A5 (https=) | ||
| JP2021529732A5 (https=) | ||
| Bhattacharya et al. | Antipyretic, anti-inflammatory and analgesic effects of leaf extract of drumstick tree | |
| Zhang et al. | Ginsenoside Rb1 alleviated concanavalin A-induced hepatocyte pyroptosis by activating mitophagy | |
| JP2023521163A5 (https=) | ||
| JP2018065878A (ja) | ロキソプロフェン含有外用剤組成物 | |
| Dutta et al. | Screening of potential anti-HIV compounds from Achyranthes aspera extracts for SARS-CoV-2: An insight from molecular docking study | |
| JP2023521162A5 (https=) | ||
| Liu et al. | Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents | |
| Pandey et al. | A review on corona virus and treatment approaches with Allium sativam | |
| Shahmohamadnejad et al. | May we target double‐membrane vesicles and oxysterol‐binding protein to combat SARS‐CoV‐2 infection? | |
| Ono et al. | Oseltamivir, an Anti-influenza Virus Drug, Produces Hypothermia in Mice Comparison Among Oseltamivir, Zanamivir and Diclofenac | |
| Costabel et al. | S12 Effect Of Baseline Fvc On Decline In Lung Function With Nintedanib: Results From The Inpulsis™ Trials | |
| CN103736100B (zh) | 预防hiv性传播的杀微生物剂酸酐修饰抗sevi多克隆抗体 | |
| CN103638155B (zh) | 治疗足跟痛的外用中药制剂 | |
| Chisick et al. | Algorithm for initial management of priapism in chronic myeloid leukaemia | |
| JP5232520B2 (ja) | ロキソプロフェンを含有する抗アデノウイルス剤 | |
| Sabarianandh et al. | COVID-19 in Siddha Medicine: A Review | |
| CN105769890A (zh) | 桔梗皂苷d在制备防治猪繁殖与呼吸综合征药物中的用途 | |
| Murugesu et al. | Molecular docking analysis of christanoate and christene from Christia vespertilionis plants as potential inhibitors of Covid-19 | |
| CN105560639A (zh) | 一种治疗带状孢疹多形渗出性红斑的中药 | |
| Lam et al. | Identification of anti-HBV activities in Paeonia suffruticosa Andr. using GRP78 as a drug target on Herbochip® |